Grant Pickering - Mar 21, 2022 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
Chief Executive Officer, Director
Signature
/s/ Ron Metzger, Attorney-in-Fact
Stock symbol
PCVX
Transactions as of
Mar 21, 2022
Transactions value $
-$506,763
Form type
4
Date filed
3/23/2022, 06:03 PM
Previous filing
Mar 4, 2022
Next filing
Apr 20, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Options Exercise $25.6K +14.3K +2.03% $1.79 718K Mar 21, 2022 Direct
transaction PCVX Common Stock Sale -$347K -13.9K -1.94% $24.92 704K Mar 21, 2022 Direct F1, F2
transaction PCVX Common Stock Sale -$9.22K -359 -0.05% $25.68 704K Mar 21, 2022 Direct F1, F3
transaction PCVX Common Stock Options Exercise $13.8K +7.71K +1.1% $1.79 712K Mar 22, 2022 Direct
transaction PCVX Common Stock Sale -$190K -7.71K -1.08% $24.62 704K Mar 22, 2022 Direct F1, F4
holding PCVX Common Stock 356K Mar 21, 2022 By Children's Trusts

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCVX Stock Option (right to buy) Options Exercise $0 -14.3K -5.13% $0.00 264K Mar 21, 2022 Common Stock 14.3K $1.79 Direct F5
transaction PCVX Stock Option (right to buy) Options Exercise $0 -7.71K -2.92% $0.00 256K Mar 22, 2022 Common Stock 7.71K $1.79 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2 The price reported is a weighted-average price. The shares were sold at prices ranging from $24.55 to $25.48. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3 The price reported is a weighted-average price. The shares were sold at prices ranging from $25.635 to $25.70. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
F4 The price reported is a weighted-average price. The shares were sold at prices ranging from $24.20 to $25.02. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
F5 The shares subject to the option are fully vested and exercisable.